Suppr超能文献

肌肉的重要性:骨骼肌指数和体重指数对肾癌并发症及生存的影响

Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer.

作者信息

Hillers Alexander Hintze, Bach Signe Wang, Saito Atena, Azawi Nessn

机构信息

Department of Urology Rigshospitalet Copenhagen Denmark.

Department of Urology Zealand University Hospital Roskilde Denmark.

出版信息

BJUI Compass. 2024 Jun 13;5(8):783-790. doi: 10.1002/bco2.405. eCollection 2024 Aug.

Abstract

OBJECTIVE

The objective of this study is to independently assess skeletal muscle index (SMI) and body mass index (BMI) as prognostic determinants for renal cell carcinoma (RCC) and investigate their correlation with surgical outcomes.

PATIENTS AND METHODS

A retrospective cohort study of 524 RCC patients diagnosed between August 2010 and July 2018 was conducted using data from the Zealand University Hospital Renal Cancer Database in Denmark. Patient information was extracted from electronic patient records and the National Cancer Registry and encompassed demographics, clinical factors, tumour characteristics and surgical details. SMI was calculated from a single third lumbar vertebra (L3) axial computed tomography (CT) image via CoreSlicer software and classified into high using gender-specific thresholds. Primary outcomes focused on complications within 90 days as well as survival outcomes, and their relation with both SMI and BMI. Multivariable analysis assessed SMI's independent prognostic significance in RCC.

RESULTS

Among 524 patients, 18.5% experienced complications, with high SMI correlating significantly ( = 0.018) with a 72% higher complication risk. High SMI patients had a 22.7% complication rate compared to 14.5% in the low SMI group. High SMI was also linked to prolonged survival (110.95 vs. 94.87 months;  = 0.001), whereas BMI showed no significant survival differences ( = 0.326). Multivariable analysis ( = 522) revealed high SMI associated with improved survival (hazard ratio [HR] = 0.738; 95% CI, 0.548-0.994;  = 0.046). Advanced T-stage significantly impacted mortality (T2: HR = 2.057; T3: HR = 4.361;  < 0.001), and each additional year of age raised mortality risk by 4.3% (HR = 1.043;  < 0.001).

CONCLUSIONS

Higher SMI increases the risk of postoperative complications, yet it significantly improves overall survival rates. Different BMI categories lack RCC prognostic significance. The increasing incidence in RCC calls for the use of CT scan to assess SMI and aid treatment planning in patients who might benefit from preoperative interventions.

摘要

目的

本研究的目的是独立评估骨骼肌指数(SMI)和体重指数(BMI)作为肾细胞癌(RCC)的预后决定因素,并研究它们与手术结果的相关性。

患者与方法

利用丹麦西兰大学医院肾癌数据库的数据,对2010年8月至2018年7月期间诊断的524例RCC患者进行了一项回顾性队列研究。患者信息从电子病历和国家癌症登记处提取,包括人口统计学、临床因素、肿瘤特征和手术细节。通过CoreSlicer软件从单个第三腰椎(L3)轴向计算机断层扫描(CT)图像计算SMI,并使用特定性别的阈值将其分类为高。主要结局集中在90天内的并发症以及生存结局,以及它们与SMI和BMI的关系。多变量分析评估了SMI在RCC中的独立预后意义。

结果

在524例患者中,18.5%发生了并发症,高SMI与并发症风险显著相关(P = 0.018)且并发症风险高出72%。高SMI患者的并发症发生率为22.7%,而低SMI组为14.5%。高SMI还与生存期延长相关(110.95对94.87个月;P = 0.001),而BMI在生存方面无显著差异(P = 0.326)。多变量分析(n = 522)显示高SMI与生存期改善相关(风险比[HR] = 0.738;95%可信区间,0.548 - 0.994;P = 0.046)。晚期T分期显著影响死亡率(T2:HR = 2.057;T3:HR = 4.361;P < 0.001),且每增加一岁死亡风险增加4.3%(HR = 1.043;P < 0.001)。

结论

较高的SMI增加了术后并发症的风险,但它显著提高了总体生存率。不同的BMI类别缺乏RCC预后意义。RCC发病率的上升要求使用CT扫描来评估SMI,并帮助可能从术前干预中获益的患者进行治疗规划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f921/11327491/6d29ff18bb4f/BCO2-5-783-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验